Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Hsueh

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Annals of Surgical Oncology|May 3, 2000
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?E C Hsueh, R K Gupta, R Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanomaM C Kelley, R K Gupta, E C Hsueh, et al.
Journal of the American College of Surgeons|August 15, 1998
Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanomaE C Hsueh, R K Gupta, E C Glass, et al.
The Cancer Journal From Scientific American|December 24, 1997
TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanomaE C Hsueh, R K Gupta, K Qi, et al.
Annals of Surgical Oncology|April 21, 2001
Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanomaG J Tsioulias, R K Gupta, G Tisman, et al.
Journal of Cellular Biochemistry|March 1, 1988
Posttranslational modification of ras proteins: detection of a modification prior to fatty acid acylation and cloning of a gene responsible for the modificationF Tamanoi, E C Hsueh, L E Goodman, et al.
Cancer|May 18, 1999
Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastasesE C Hsueh, L Nathanson, L J Foshag, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Annals of Surgical Oncology|May 3, 2000
Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?E C Hsueh, R K Gupta, R Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanomaM C Kelley, R K Gupta, E C Hsueh, et al.
Journal of the American College of Surgeons|August 15, 1998
Positron emission tomography plus serum TA90 immune complex assay for detection of occult metastatic melanomaE C Hsueh, R K Gupta, E C Glass, et al.
The Cancer Journal From Scientific American|December 24, 1997
TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanomaE C Hsueh, R K Gupta, K Qi, et al.
Annals of Surgical Oncology|April 21, 2001
Serum TA90 antigen-antibody complex as a surrogate marker for the efficacy of a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanomaG J Tsioulias, R K Gupta, G Tisman, et al.
Journal of Cellular Biochemistry|March 1, 1988
Posttranslational modification of ras proteins: detection of a modification prior to fatty acid acylation and cloning of a gene responsible for the modificationF Tamanoi, E C Hsueh, L E Goodman, et al.
Cancer|May 18, 1999
Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastasesE C Hsueh, L Nathanson, L J Foshag, et al.
Pageof 2